Literature DB >> 2442271

A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitis D virus.

C Pohl, B M Baroudy, K F Bergmann, P J Cote, R H Purcell, J Hoofnagle, J L Gerin.   

Abstract

Peripheral blood lymphocytes from a patient chronically infected with hepatitis D virus (HDV) were immortalized by Epstein-Barr virus transformation. Two stable monoclonal cell lines, derived from the same parent culture, were established and produced antibodies of the IgG isotype that were specific for the hepatitis delta antigen (HDAg). Both monoclonal antibodies (MAbs) recognized the major HDAg polypeptides of 24 kilodaltons and 27 kilodaltons that were previously detected by polyclonal antibodies to HDAg in both liver and serum from HDV-infected humans, chimpanzees, and woodchucks. This result indicates that the major polypeptides of HDAg share common epitopes. The MAbs also reacted with minor polypeptides of lower molecular weight, which were present in infected liver. In vitro translation products of HDV-specific RNA from infected liver were also detected by the MAbs; these polypeptides were 24 kilodaltons and 27 kilodaltons, respectively, and comigrated with liver- or serum-derived HDAg. In contrast, HDV RNA isolated from virions in serum was not translated into HDAg polypeptides in the in vitro system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442271     DOI: 10.1093/infdis/156.4.622

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

Review 1.  Immunopathogenesis of viral hepatitis.

Authors:  M U Mondelli
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases.

Authors:  L E Modahl; T B Macnaughton; N Zhu; D L Johnson; M M Lai
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

3.  Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen.

Authors:  Y P Xia; M M Lai
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

4.  A specific base transition occurs on replicating hepatitis delta virus RNA.

Authors:  G X Luo; M Chao; S Y Hsieh; C Sureau; K Nishikura; J Taylor
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

5.  The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication.

Authors:  L E Modahl; M M Lai
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Local helix content and RNA-binding activity of the N-terminal leucine-repeat region of hepatitis delta antigen.

Authors:  J W Cheng; I J Lin; Y C Lou; M T Pai; H N Wu
Journal:  J Biomol NMR       Date:  1998-07       Impact factor: 2.835

7.  Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity.

Authors:  M F Chang; S C Baker; L H Soe; T Kamahora; J G Keck; S Makino; S Govindarajan; M M Lai
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

8.  Immune response to synthetic peptides of hepatitis delta antigen.

Authors:  F Poisson; F Baillou; F Dubois; B Janvier; P Roingeard; A Goudeau
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Nuclear localization signals, but not putative leucine zipper motifs, are essential for nuclear transport of hepatitis delta antigen.

Authors:  M F Chang; S C Chang; C I Chang; K Wu; H Y Kang
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Multimerization of hepatitis delta antigen is a critical determinant of RNA binding specificity.

Authors:  Brian C Lin; Dawn A Defenbaugh; John L Casey
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.